ZIOPHARM ONCOLOGY INC·4

Oct 2, 4:31 PM ET

MAUNEY DAVID M MD 4

4 · ZIOPHARM ONCOLOGY INC · Filed Oct 2, 2017

Insider Transaction Report

Form 4
Period: 2017-09-28
MAUNEY DAVID M MD
EVP and Chief Business Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2017-09-28+500,000500,000 total
    Exercise: $6.19Exp: 2027-09-28Common Stock (500,000 underlying)
Footnotes (1)
  • [F1]166,667 shares subject to the option shall vest on each of 9/28/2018 and 9/28/2019; 166,666 shares subject to the option shall vest on 9/28/2020.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION